127 related articles for article (PubMed ID: 10793025)
41. The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM.
Vleming LJ; van der Pijl JW; Lemkes HH; Westendorp RG; Maassen JA; Daha MR; van Es LA; van Kooten C
Clin Nephrol; 1999 Mar; 51(3):133-40. PubMed ID: 10099885
[TBL] [Abstract][Full Text] [Related]
42. Angiotensin I-converting enzyme gene polymorphism in non-diabetic renal disease.
Samuelsson O; Attman PO; Larsson R; Mulec H; Rymo L; Weiss L; Ricksten A
Nephrol Dial Transplant; 2000 Apr; 15(4):481-6. PubMed ID: 10727542
[TBL] [Abstract][Full Text] [Related]
43. ACE genotype and progression of IgA nephropathy.
Fukushima T; Nomura S; Kawai S; Osawa G
Lancet; 1995 Aug; 346(8974):571. PubMed ID: 7658790
[No Abstract] [Full Text] [Related]
44. A Pooled Study of Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphism in Relation to Risk, Pathology and Prognosis of Childhood Immunoglobulin A Vasculitis Nephritis.
Hui G; Cheng Z; Ran H; Ziwei W; Fang D
Biochem Genet; 2021 Feb; 59(1):202-218. PubMed ID: 32980913
[TBL] [Abstract][Full Text] [Related]
45. Disease progression, response to ACEI/ATRA therapy and influence of ACE gene in IgA nephritis.
Woo KT; Lau YK; Zhao Y; Liu FE; Tan HB; Tan EK; Stephanie FC; Chan CM; Wong KS
Cell Mol Immunol; 2007 Jun; 4(3):227-32. PubMed ID: 17601378
[TBL] [Abstract][Full Text] [Related]
46. [Angiotensin-converting enzyme gene polymorphism and the clinical pathological features and progression in lupus nephritis].
Guan T; Liu Z; Chen Z
Zhonghua Nei Ke Za Zhi; 1997 Jul; 36(7):461-4. PubMed ID: 10436947
[TBL] [Abstract][Full Text] [Related]
47. Angiotensin-converting enzyme gene polymorphism in patients with systemic lupus.
Prkacin I; Novak B; Sertić J; Mrzljak A
Acta Med Croatica; 2001; 55(2):73-6. PubMed ID: 11505631
[TBL] [Abstract][Full Text] [Related]
48. Association of angiotensin I-converting enzyme gene insertion/deletion polymorphism and IgA nephropathy: a meta-analysis.
Yong D; Qing WQ; Hua L; Kan JJ; Xi CJ; Jin QQ; Chao SH
Am J Nephrol; 2006; 26(5):511-8. PubMed ID: 17124384
[TBL] [Abstract][Full Text] [Related]
49. Angiotensin converting enzyme gene polymorphism and renal hemodynamic function in early diabetes.
Miller JA; Scholey JW; Thai K; Pei YP
Kidney Int; 1997 Jan; 51(1):119-24. PubMed ID: 8995725
[TBL] [Abstract][Full Text] [Related]
50. [Angiotensin converting enzyme (ACE) gene polymorphism in a diabetic cohort and diabetic nephropathy].
Levinson O; Oren S; Yagil C; Sapojnikov M; Wechsler A; Bloch R; Yagil Y
Harefuah; 1999 May; 136(10):768-73, 843. PubMed ID: 10955109
[TBL] [Abstract][Full Text] [Related]
51. Angiotensin-converting enzyme gene polymorphism is correlated to the progression of disease in patients with IgA nephropathy: a meta-analysis.
Wiwanitkit V
Ren Fail; 2006; 28(8):697-9. PubMed ID: 17162429
[TBL] [Abstract][Full Text] [Related]
52. ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1.
Perna A; Ruggenenti P; Testa A; Spoto B; Benini R; Misefari V; Remuzzi G; Zoccali C
Kidney Int; 2000 Jan; 57(1):274-81. PubMed ID: 10620209
[TBL] [Abstract][Full Text] [Related]
53. Antiproteinuric effect of losartan in non-diabetic renal disease is not dependent on ACE insertion/deletion polymorphism.
Park HC; Choi HY; Kim BS; Kang SW; Choi KH; Ha SK; Lee HY; Han DS
Kidney Blood Press Res; 2006; 29(4):216-24. PubMed ID: 16960460
[TBL] [Abstract][Full Text] [Related]
54. Insertion/deletion angiotensin converting enzyme gene polymorphism affects the microvascular structure of the kidney in patients with nondiabetic renal disease.
Teranishi M; Ono H; Ishimitsu T; Matsuoka H
J Hypertens; 1999 Mar; 17(3):351-6. PubMed ID: 10100072
[TBL] [Abstract][Full Text] [Related]
55. Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM.
Penno G; Chaturvedi N; Talmud PJ; Cotroneo P; Manto A; Nannipieri M; Luong LA; Fuller JH
Diabetes; 1998 Sep; 47(9):1507-11. PubMed ID: 9726242
[TBL] [Abstract][Full Text] [Related]
56. [Angiotensin-converting enyme insertion/deletion polymorphism and blood pressure regulation in type 2 diabetic patients].
Krajina-Andricević M; Zibar L; Glavas-Obrovac- L; Stefanić M; Avdicević M; Barbić J
Acta Med Croatica; 2011 Oct; 65 Suppl 3():14-9. PubMed ID: 23120809
[TBL] [Abstract][Full Text] [Related]
57. ACE I/D gene polymorphism predicts renal damage in congenital uropathies.
Hohenfellner K; Hunley TE; Brezinska R; Brodhag P; Shyr Y; Brenner W; Habermehl P; Kon V
Pediatr Nephrol; 1999 Aug; 13(6):514-8. PubMed ID: 10452281
[TBL] [Abstract][Full Text] [Related]
58. Angiotensin-converting enzyme insertion/deletion polymorphism and diabetic albuminuria in patients with NIDDM followed Up for 9 years.
Huang XH; Rantalaiho V; Wirta O; Pasternack A; Hiltunen TP; Koivula T; Malminiemi K; Nikkari T; Lehtimäki T
Nephron; 1998 Sep; 80(1):17-24. PubMed ID: 9730698
[TBL] [Abstract][Full Text] [Related]
59. Proteinuria and angiotensin converting enzyme (ACE) gene polymorphism.
Woo KT; Lau YK
Ann Acad Med Singap; 2000 May; 29(3):383-7. PubMed ID: 10976394
[TBL] [Abstract][Full Text] [Related]
60. Renin-angiotensin system gene polymorphisms: its impact on IgAN and its progression to end-stage renal failure among Chinese in Singapore.
Lau YK; Woo KT; Choong HL; Zhao Y; Tan HB; Chong SM; Tan EK; Yap HK; Wong KS
Nephron Physiol; 2004; 97(1):p1-8. PubMed ID: 15153745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
